Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-07 Exercise | 2024-11-12 4:17 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 3,750 | $0 | 94,939 (Direct) | View |
| 2024-11-07 Tax Withholding | 2024-11-12 4:17 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 1,102 | $6.04 | 94,939 (Direct) | View |
| 2024-09-18 Tax Withholding | 2024-09-20 4:13 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 1,837 | $6.38 | 81,791 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-17 5:12 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 2,250 | $0 | 97,878 (Direct) | View |
| 2024-09-16 Tax Withholding | 2024-09-17 5:12 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 661 | $6.36 | 97,878 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-08 7:21 pm | N/A 2032-02-13 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:21 pm | N/A 2032-02-13 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 5:02 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 1,301 | $6.53 | 247,339 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:02 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 202,000 | $0 | 247,339 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:21 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 136,000 | $0 | 157,640 (Direct) | View |
Ownership | 2023-09-19 7:20 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 0 | $0 | 215,515 (Direct) | View |